Novel Allogeneic CAR T Therapy Shows Promise for Metastatic Renal Cell Carcinoma,The CD70-targeting allogeneic...
MD Anderson Cancer Center
Mutations in 3 Genes Linked to Poor Lung Cancer Treatment Outcomes,A new study led...
YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers
3 min read
YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers,The first-in-class YAP/TEAD inhibitor...
